alexa Jean-Philippe Kevorkian | Lariboisière Hospital
ISSN: 2155-9880

Journal of Clinical & Experimental Cardiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Jean-Philippe Kevorkian

 Lariboisière Hospital France

 Jean Philipp KEVORKIAN is full time in the Endocrinology Service and metabolisms- Internal Medicine within AP-HP Groupe hospitalier Lariboisière - Fernand-Widal (Paris) (CHU (University Hospital Hospital dependent of a)). AP-HP Groupe hospitalier Lariboisière - Fernand-Widal (Paris) is headed by Mr. Rémi FERAUD.

Research Interest

 Platelet reactivity; P2Y12 receptor antagonist; Diabetes, diabetes mellitus, acute coronary syndrome, antiplatelet therapy, Clopidogrel


Antiplatelet Agents in Diabetic Patients: Clinical Advances and Remaining Questions

Pierre Sabouret, Magali Taiel-Sartral, Jean-Philippe Kevorkian, Bruno Vergès

Review Article: J Clin Exp Cardiolog 2014, 5:330

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version